🇺🇸 FDA
Pipeline program

DS-5141b

DS5141-A-J201

Phase 2 small_molecule active

Quick answer

DS-5141b for Duchenne Muscular Dystrophy is a Phase 2 program (small_molecule) at Daiichi Sankyo with 1 ClinicalTrials.gov record(s).

Program details

Company
Daiichi Sankyo
Indication
Duchenne Muscular Dystrophy
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials